Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | JAK1 | P23458 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8261299 | 1.00 | HTT (0.47) | HTTLMNAHPGDCYP3A4CYP2D6 | |
| SCHEMBL14233304 | 0.96 | HPGD (0.48) | HPGD | |
| SCHEMBL8261301 | 0.94 | LMNA (0.49) | HTTLMNAHPGDJAK1 | |
| SCHEMBL19369982 | 0.88 | HTT (0.53) | HTTLMNA | |
| SCHEMBL8194282 | 0.88 | HTT (0.53) | HTTLMNA | |
| SCHEMBL20199815 | 0.88 | HTT (0.53) | HTTLMNA | |
| SCHEMBL26615251 | 0.86 | JAK1 (0.44) | CYP3A4CYP2D6JAK1 | |
| SCHEMBL29008786 | 0.86 | JAK1 (0.44) | CYP3A4CYP2D6JAK1 | |
| SCHEMBL15014605 | 0.86 | ALDH1A1 (0.43) | CYP3A4CYP2D6JAK1 | |
| SCHEMBL15014480 | 0.86 | ALDH1A1 (0.43) | CYP3A4CYP2D6JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9327993-B2 | Method for preparing rare earth fluoride nanoparticles | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2016-05-03 | — | — | US | disclosed |
| US-9327993-B2 | Method for preparing rare earth fluoride nanoparticles | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2016-05-03 | — | — | US | disclosed |
| US-20120164049-A1 | METHOD FOR PREPARING RARE EARTH FLUORIDE NANOPARTICLES | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2012-06-28 | — | — | US | disclosed |
| US-20120164049-A1 | METHOD FOR PREPARING RARE EARTH FLUORIDE NANOPARTICLES | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164049-A1 | METHOD FOR PREPARING RARE EARTH FLUORIDE NANOPARTICLES | NAF1, RAB1A, RFT1 | HTT 1823/4885LMNA 1782/4885HPGD 4605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.